Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Preceptorship on Urothelial Cancer 2021

17 - 18 Nov 2021



Slides and Webcasts from all ESMO Preceptorships are open to all ESMO account holders, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives
  • To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder cancer
  • To understand essentials in the assessment and multidisciplinary treatment of bladder cancer
  • To learn about advances in treatment and novel targets in bladder cancer

This course was part of the ESMO Asia Virtual Oncology Week 2021 programme

More from this event

Filter by:

There are 18 resources available

CPI based regimen toxicity

Presenter: L. Albiges, FR

Session: Session 6 - Side effects management




ADC toxicity

Presenter: R. Kanesvaran, SG

Session: Session 6 - Side effects management




This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.